ALA 1.35% 18.3¢ arovella therapeutics limited

HD: I agree that number 2 option is the best opportunity for...

  1. 571 Posts.
    lightbulb Created with Sketch. 41
    HD:

    I agree that number 2 option is the best opportunity for SH's. I don't want to wait anymore years for a profit.

    A trade sale, large upfront or buyout of the hydrotrope IP is what I hope for.
    What we should all agree on is that SUDA has assets that can be monetised; when and how much are unknown.
    Artimist
    WC
    Hydrotrope IP, either individually or as a whole.

    These offer a lot of hope compared to many peer micro biotechs, who may only have a potential drug in phase 1 or 2 trials. These may be blockbusters eventually or nothing at all.
    Hopefully the above will be sold and give us all a lift.
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
18.3¢
Change
-0.003(1.35%)
Mkt cap ! $192.7M
Open High Low Value Volume
18.5¢ 18.5¢ 18.0¢ $67.23K 363.8K

Buyers (Bids)

No. Vol. Price($)
9 640678 18.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.5¢ 110835 5
View Market Depth
Last trade - 13.43pm 05/11/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.